Table 4.
The multiple linear regression analysis for clinical parameters with the electrocardiogram in T2DM patients.
| Indices | Heart rate | PR interval | QTc interval | |||
|---|---|---|---|---|---|---|
| β | P | β | P | β | P | |
| DR stage | 1.593 | 0.027 | 4.666 | 0.001 | 8.807 | 0.005 |
| Age | -0.032 | 0.485 | 0.386 | <0.001 | 0.155 | 0.429 |
| Male | -1.425 | 0.170 | 6.000 | 0.004 | -14.335 | 0.001 |
| DBP | 0.152 | 0.004 | -0.249 | 0.018 | 0.304 | 0.177 |
| SBP | -0.011 | 0.743 | 0.164 | 0.018 | -0.168 | 0.254 |
| Hypertension | 0.926 | 0.425 | 1.514 | 0.519 | 10.226 | 0.041 |
| Total cholesterol | 0.881 | 0.031 | -0.079 | 0.924 | 4.881 | 0.006 |
| HDL-C | -0.562 | 0.558 | -1.882 | 0.333 | -8.600 | 0.038 |
| Diabetic nephropathy | 2.574 | 0.015 | 3.252 | 0.129 | 1.398 | 0.759 |
| Smoking history | 0.162 | 0.871 | 0.644 | 0.748 | -4.715 | 0.270 |
| Diabetes duration | -0.004 | 0.959 | -0.299 | 0.069 | -0.068 | 0.846 |
| ACEI/ARB use | 0.948 | 0.455 | 0.004 | 0.912 | -5.423 | 0.322 |
| Insulin use | 1.789 | 0.044 | 3.737 | 0.038 | 11.076 | 0.004 |
Note: bold indicated value of p < 0.05.